The Amyotrophic Lateral Sclerosis Association and SOLA Biosciences entered a Research Grant Agreement to advance ALS animal efficacy studies of SOL-257.

Series Pre-A Financing completed with MP Healthcare Venture Management Inc. and Eisai Innovation Inc.